Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prediction of GluN2B-CT1290-1310/DAPK1 Interaction by Protein–Peptide Docking and Molecular Dynamics Simulation
Gao Tu, Tingting Fu, Fengyuan Yang, et al.
Molecules (2018) Vol. 23, Iss. 11, pp. 3018-3018
Open Access | Times Cited: 20

Showing 20 citing articles:

How Does Chirality Determine the Selective Inhibition of Histone Deacetylase 6? A Lesson from Trichostatin A Enantiomers Based on Molecular Dynamics
Yang Zhang, Jun Ying, Jia Jun Hong, et al.
ACS Chemical Neuroscience (2019) Vol. 10, Iss. 5, pp. 2467-2480
Closed Access | Times Cited: 89
Revealing the magic of acupuncture based on biological mechanisms: A literature review
Bo Zhang, Haojun Shi, Shengnan Cao, et al.
BioScience Trends (2022) Vol. 16, Iss. 1, pp. 73-90
Open Access | Times Cited: 51
Computational design and modeling of nanobodies toward SARS‐CoV‐2 receptor binding domain
Jingyi Yang, Zhao Zhang, Fengyuan Yang, et al.
Chemical Biology & Drug Design (2021) Vol. 98, Iss. 1, pp. 1-18
Open Access | Times Cited: 52
Protein-protein interactions at the NMDA receptor complex: From synaptic retention to synaptonuclear protein messengers
Fabrizio Gardoni, Mónica Di Luca
Neuropharmacology (2021) Vol. 190, pp. 108551-108551
Open Access | Times Cited: 34
Regulation of Synaptic NMDA Receptor Activity by Post-Translational Modifications
Emanuel Tahiri, Elisa Corti, Carlos B. Duarte
Neurochemical Research (2025) Vol. 50, Iss. 2
Open Access
Molecular mechanism of ZER1-mediated recognition of N-terminal glycine in protein degradation
Chengeng Liu, Shun Zhang, Xiafei Hao, et al.
Journal of Biomolecular Structure and Dynamics (2025), pp. 1-13
Closed Access
Molecular Simulation of Oncostatin M and Receptor (OSM–OSMR) Interaction as a Potential Therapeutic Target for Inflammatory Bowel Disease
Qingqing Du, Qian Yan, Weiwei Xue
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 29
Biomarker Discovery for Immunotherapy of Pituitary Adenomas: Enhanced Robustness and Prediction Ability by Modern Computational Tools
Qingxia Yang, Yunxia Wang, Song Zhang, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 1, pp. 151-151
Open Access | Times Cited: 25
Icaritin alleviates cerebral ischemia‒reperfusion injury by regulating NMDA receptors through ERK signaling
Song Liu, Lijiao Xiong, Zining Yu, et al.
European Journal of Pharmacology (2023) Vol. 941, pp. 175492-175492
Open Access | Times Cited: 7
Research on Bitter Peptides in the Field of Bioinformatics: A Comprehensive Review
Shanghua Liu, Tianyu Shi, Junwen Yu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9844-9844
Open Access | Times Cited: 2
Icaritin Alleviates Glutamate-Induced Neuronal Damage by Inactivating GluN2B-Containing NMDARs Through the ERK/DAPK1 Pathway
Song Liu, Chaoming Liu, Lijiao Xiong, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 16
Identification of Key Long Non-Coding RNAs in the Pathology of Alzheimer’s Disease and their Functions Based on Genome-Wide Associations Study, Microarray, and RNA-seq Data
Zhijie Han, Weiwei Xue, Lin Tao, et al.
Journal of Alzheimer s Disease (2019) Vol. 68, Iss. 1, pp. 339-355
Closed Access | Times Cited: 15
The α2δ-1-NMDA receptor complex and its potential as a therapeutic target for ischemic stroke
Tao Wu, Shaorui Chen, Hui‐Lin Pan, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 4
A Study on the Binding Mechanism and the Impact of Key Residue Mutations between SND1 and MTDH Peptide through Molecular Dynamics Simulations
Senchen Liu, Xiafei Hao, Dongqiang Miao, et al.
The Journal of Physical Chemistry B (2024)
Closed Access | Times Cited: 1
Comparative Proteomics Unveils LRRFIP1 as a New Player in the DAPK1 Interactome of Neurons Exposed to Oxygen and Glucose Deprivation
Núria DeGregorio‐Rocasolano, Verónica Guirao, Jovita Ponce, et al.
Antioxidants (2020) Vol. 9, Iss. 12, pp. 1202-1202
Open Access | Times Cited: 8
Exploring the Binding Mechanism of NRG1–ERBB3 Complex and Discovery of Potent Natural Products to Reduce Diabetes-Assisted Breast Cancer Progression
Sulaiman K. Marafie, Eman Alshawaf, Mohamed Abu‐Farha, et al.
Interdisciplinary Sciences Computational Life Sciences (2023) Vol. 15, Iss. 3, pp. 452-464
Open Access | Times Cited: 2
In Silico Study Examining New Phenylpropanoids Targets with Antidepressant Activity
Poliane da Silva Calixto, Reinaldo Nóbrega de Almeida, Mirian Graciela da Silva Stiebbe Salvadori, et al.
Current Drug Targets (2020) Vol. 22, Iss. 5, pp. 539-554
Closed Access | Times Cited: 4
In silico analysis of a novel protein in CAR T- cell therapy for the treatment of hematologic cancer through molecular modelling, docking, and dynamics approach
Rimjhim Mohanty, Manoswini Manoswini, Ajit Kumar Dhal, et al.
Computers in Biology and Medicine (2022) Vol. 151, pp. 106285-106285
Closed Access | Times Cited: 3
Recent Technological Advances in the Mass Spectrometry-based Nanomedicine Studies: An Insight from Nanoproteomics
Jing Tang, Yunxia Wang, Yi Li, et al.
Current Pharmaceutical Design (2019) Vol. 25, Iss. 13, pp. 1536-1553
Closed Access | Times Cited: 3
Rational Design of Anti‐Epileptic Peptides to Inhibit MAPK/MKP‐2 Interactions for Epilepsy Therapeutics**
Sumera Zaib, Fatima Akram, Syed Talha Liaqat, et al.
ChemistrySelect (2022) Vol. 7, Iss. 18
Closed Access
Page 1

Scroll to top